| 000 | 01899 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517011535.0 | ||
| 264 | 0 | _c20150423 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-014-2667-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNikanjam, Mina | |
| 245 | 0 | 0 |
_aPopulation pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cMar 2015 |
||
| 300 |
_a495-503 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aMonte Carlo Method |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aStewart, Clinton F | |
| 700 | 1 | _aTakimoto, Chris H | |
| 700 | 1 | _aSynold, Timothy W | |
| 700 | 1 | _aBeaty, Orren | |
| 700 | 1 | _aFouladi, Maryam | |
| 700 | 1 | _aCapparelli, Edmund V | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 75 _gno. 3 _gp. 495-503 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-014-2667-6 _zAvailable from publisher's website |
| 999 |
_c24504705 _d24504705 |
||